Notes
see Reactions 1580 p1; 803157072 and see Reactions 1497 p2-3; 803101791
Reference
US Food and Drug Administration. FDA approves first generic naloxone nasal spray to treat opioid overdose. Internet Document : 19 Apr 2019. Available from: URL: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm636333.htm
Rights and permissions
About this article
Cite this article
US FDA approves first generic naloxone spray. Reactions Weekly 1750, 7 (2019). https://doi.org/10.1007/s40278-019-60871-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-60871-6